Sara Pai is a Head & Neck physician affiliated with Yale University. OpenAlex indexes 292 publications with 13,007 citations (h-index 51); ClinicalTrials.gov lists 6 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Otolaryngology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCs
Sponsor: Yale University
- The Natural History and Biological Study of Pulmonary Recurrent Respiratory Papillomatosis (pRRP)
Sponsor: Massachusetts General Hospital
- Merck IIT: RRP Pembro and Lenvatinib
Sponsor: Yale University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
15 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
NIH funding
3 NIH research awards on record, funded 2023–2026 per NIH RePORTER. The latest:
- Cue-101 and TCR-T cell Combinatorial Strategy for HPV+ Head and Neck Cancers
Yale University
FY2026$675,007R01CA278212 - Early detection and risk of head and neck cancer through immune based spatial omics
Yale University
FY2026$614,017U01DE033324 - Early detection and risk of head and neck cancer through immune based spatial omics
Yale University
FY2025$677,643U01DE033324
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy
Science Immunology
2021 - A Randomized Phase 2 Study of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
International Journal of Radiation Oncology*Biology*Physics
2020
Similar KOLs
Other experts from the same institution or the same specialty.
John Krystal, MD
Yale University
Lajos Pusztai, MD
Yale University
Lee Schwamm, MD
Yale University
Naftali Kaminski, MD
Yale University
Everett Vokes, MD
University of Chicago
Maura Gillison, MD
The University of Texas MD Anderson Cancer Center
Christine Chung, MD
Moffitt Cancer Center
Tanguy Seiwert, MD
Johns Hopkins University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”